Your browser doesn't support javascript.
loading
Long-term results after resection of primary duodenal adenocarcinoma: A retrospective cohort study.
Jensen, Kristian K; Storkholm, Jan H; Chen, Inna; Burgdorf, Stefan K; Hansen, Carsten P.
Afiliación
  • Jensen KK; Department of Surgery, Rigshospitalet, Copenhagen, Denmark. Electronic address: mail@kristiankiim.dk.
  • Storkholm JH; Department of Surgery, Rigshospitalet, Copenhagen, Denmark.
  • Chen I; Department of Clinical Oncology, Herlev Hospital, Herlev, Denmark.
  • Burgdorf SK; Department of Surgery, Rigshospitalet, Copenhagen, Denmark.
  • Hansen CP; Department of Surgery, Rigshospitalet, Copenhagen, Denmark.
Int J Surg ; 100: 106599, 2022 Apr.
Article en En | MEDLINE | ID: mdl-35283320
ABSTRACT

BACKGROUND:

Radical resection of duodenal adenocarcinoma (DA) offers the possibility of cure. The outcome after operation and adjuvant therapy is mainly based on small numbers due to the low incidence of the disease. We examined the long-term outcome after surgical treatment of DA. MATERIAL AND

METHODS:

This was a retrospective cohort study including all patients undergoing curatively intended resection for histologically confirmed DA at a single University hospital. Long-term survival was examined by the Kaplan-Meier method and compared with the log-rank test. Multivariable Cox proportional hazards regression analysis was applied to adjust for confounding.

RESULTS:

A total of 96 patients were included. The median follow-up was 3.7 years (IQR 2.9-4.3), during which 18 patients (18.5%) had recurrence and 35 (36.5%) patients had died. The 3- and 5-year overall survival was 66.3% (55.6-76.9%) and 58.2% (46.2-70.2%), respectively. In the multivariable analysis, adjuvant therapy was associated with decreased mortality (HR 0.29, CI 0.11-0.76, P = 0.011) whereas positive lymph node ratio >0.20 was associated with increased mortality.

CONCLUSION:

Radical operation for DA has a median overall 5-year-survival of more than 50%. The indication for adjuvant chemotherapy remains to be addressed.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Adenocarcinoma / Neoplasias Duodenales Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Surg Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Adenocarcinoma / Neoplasias Duodenales Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Surg Año: 2022 Tipo del documento: Article